JAK2 c.1821G>C ;(p.K607N)

Variant ID: 9-5073742-G-C

NM_004972.3(JAK2):c.1821G>C;(p.K607N)

This variant was identified in 20 publications

View GRCh38 version.




Publications:


Network expansion of genetic associations defines a pleiotropy map of human cell biology.

Nature Genetics
Barrio-Hernandez, Inigo I; Schwartzentruber, Jeremy J; Shrivastava, Anjali A; Del-Toro, Noemi N; Gonzalez, Asier A; Zhang, Qian Q; Mountjoy, Edward E; Suveges, Daniel D; Ochoa, David D; Ghoussaini, Maya M; Bradley, Glyn G; Hermjakob, Henning H; Orchard, Sandra S; Dunham, Ian I; Anderson, Carl A CA; Porras, Pablo P; Beltrao, Pedro P
Publication Date: 2023-02-23

Variant appearance in text: JAK2: 1821G>C; Lys607Asn
PubMed Link: 36823319
Variant Present in the following documents:
  • 41588_2023_1327_MOESM4_ESM.xlsx, sheet 6
View BVdb publication page



Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.

Nature Communications
Gounder, Mrinal M MM; Agaram, Narasimhan P NP; Trabucco, Sally E SE; Robinson, Victoria V; Ferraro, Richard A RA; Millis, Sherri Z SZ; Krishnan, Anita A; Lee, Jessica J; Attia, Steven S; Abida, Wassim W; Drilon, Alexander A; Chi, Ping P; Angelo, Sandra P D' SP; Dickson, Mark A MA; Keohan, Mary Lou ML; Kelly, Ciara M CM; Agulnik, Mark M; Chawla, Sant P SP; Choy, Edwin E; Chugh, Rashmi R; Meyer, Christian F CF; Myer, Parvathi A PA; Moore, Jessica L JL; Okimoto, Ross A RA; Pollock, Raphael E RE; Ravi, Vinod V; Singh, Arun S AS; Somaiah, Neeta N; Wagner, Andrew J AJ; Healey, John H JH; Frampton, Garrett M GM; Venstrom, Jeffrey M JM; Ross, Jeffrey S JS; Ladanyi, Marc M; Singer, Samuel S; Brennan, Murray F MF; Schwartz, Gary K GK; Lazar, Alexander J AJ; Thomas, David M DM; Maki, Robert G RG; Tap, William D WD; Ali, Siraj M SM; Jin, Dexter X DX
Publication Date: 2022-06-15

Variant appearance in text: JAK2: K607N
PubMed Link: 35705558
Variant Present in the following documents:
  • 41467_2022_30496_MOESM2_ESM.xls, sheet 1
View BVdb publication page



C/EBPβ regulates the JAK/STAT signaling pathway in triple-negative breast cancer.

Febs Open Bio
Wang, Shu S; Xia, Dian D; Wang, Xianzhi X; Cao, Haowei H; Wu, Chaoshen C; Sun, Zhaoran Z; Zhang, Daoyong D; Liu, Hao H
Publication Date: 2021-04

Variant appearance in text: JAK2: K607N
PubMed Link: 33660927
Variant Present in the following documents:
  • FEB4-11-1250.pdf
View BVdb publication page



Rae1 drives NKG2D binding-dependent tumor development in mice by activating mTOR and STAT3 pathways in tumor cells.

Cancer Science
Zhao, Peiyan P; Yang, Lei L; Li, Xin X; Lu, Wenting W; Lu, Fangjie F; Wang, Shengnan S; Wang, Ying Y; Hua, Li L; Cui, Cuiyun C; Dong, Boqi B; Yu, Yongli Y; Wang, Liying L
Publication Date: 2020-07

Variant appearance in text: JAK2: K607N
PubMed Link: 32333709
Variant Present in the following documents:
  • CAS-111-2234.pdf
View BVdb publication page



Prospects for pharmacological targeting of pseudokinases.

Nature Reviews. Drug Discovery
Kung, Jennifer E JE; Jura, Natalia N
Publication Date: 2019-07

Variant appearance in text: JAK2: K607N
PubMed Link: 30850748
Variant Present in the following documents:
  • Main text
View BVdb publication page



Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board.

Jco Precision Oncology
Dalton, W Brian WB; Forde, Patrick M PM; Kang, Hyunseok H; Connolly, Roisin M RM; Stearns, Vered V; Gocke, Christopher D CD; Eshleman, James R JR; Axilbund, Jennifer J; Petry, Dana D; Geoghegan, Cindy C; Wolff, Antonio C AC; Loeb, David M DM; Pratilas, Christine A CA; Meyer, Christian F CF; Christenson, Eric S ES; Slater, Shannon A SA; Ensminger, Jennifer J; Parsons, Heather A HA; Park, Ben H BH; Lauring, Josh J
Publication Date: 2017

Variant appearance in text: JAK2: K607N
PubMed Link: 30003184
Variant Present in the following documents:
  • Main text
View BVdb publication page



The New Genomics: What Molecular Databases Can Tell Us About Human Population Variation and Endocrine Disease.

Endocrinology
Rotwein, Peter P
Publication Date: 2017-07-01

Variant appearance in text: JAK2: K607N
PubMed Link: 28498917
Variant Present in the following documents:
  • Main text
View BVdb publication page



The reliable assurance of detecting somatic mutations in cancer-related genes by next-generation sequencing: the results of external quality assessment in China.

Oncotarget
Zhang, Rui R; Ding, Jiansheng J; Han, Yanxi Y; Yi, Lang L; Xie, Jiehong J; Yang, Xin X; Fan, Gaowei G; Wang, Guojing G; Hao, Mingju M; Zhang, Dong D; Zhang, Kuo K; Lin, Guigao G; Li, Jinming J
Publication Date: 2016-09-06

Variant appearance in text: JAK2: 1821G>C; lys607Asn
PubMed Link: 27542269
Variant Present in the following documents:
  • Main text
  • oncotarget-07-58500.pdf
View BVdb publication page



iFish: predicting the pathogenicity of human nonsynonymous variants using gene-specific/family-specific attributes and classifiers.

Scientific Reports
Wang, Meng M; Wei, Liping L
Publication Date: 2016-08-16

Variant appearance in text: JAK2: K607N
PubMed Link: 27527004
Variant Present in the following documents:
  • srep31321-s4.xls, sheet 1
View BVdb publication page



Kinome-wide decoding of network-attacking mutations rewiring cancer signaling.

Cell
Creixell, Pau P; Schoof, Erwin M EM; Simpson, Craig D CD; Longden, James J; Miller, Chad J CJ; Lou, Hua Jane HJ; Perryman, Lara L; Cox, Thomas R TR; Zivanovic, Nevena N; Palmeri, Antonio A; Wesolowska-Andersen, Agata A; Helmer-Citterich, Manuela M; Ferkinghoff-Borg, Jesper J; Itamochi, Hiroaki H; Bodenmiller, Bernd B; Erler, Janine T JT; Turk, Benjamin E BE; Linding, Rune R
Publication Date: 2015-09-24

Variant appearance in text: JAK2: K607N
PubMed Link: 26388441
Variant Present in the following documents:
  • mmc3.xlsx, sheet 1
View BVdb publication page



GESPA: classifying nsSNPs to predict disease association.

Bmc Bioinformatics
Khurana, Jay K JK; Reeder, Jay E JE; Shrimpton, Antony E AE; Thakar, Juilee J
Publication Date: 2015-07-25

Variant appearance in text: JAK2: K607N
PubMed Link: 26206375
Variant Present in the following documents:
  • 12859_2015_673_MOESM1_ESM.xls, sheet 5
View BVdb publication page



Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase.

Nature Structural & Molecular Biology
Shan, Yibing Y; Gnanasambandan, Kavitha K; Ungureanu, Daniela D; Kim, Eric T ET; Hammarén, Henrik H; Yamashita, Kazuo K; Silvennoinen, Olli O; Shaw, David E DE; Hubbard, Stevan R SR
Publication Date: 2014-07

Variant appearance in text: N/A
PubMed Link: 24918548
Variant Present in the following documents:
View BVdb publication page



Molecular pathways: molecular basis for sensitivity and resistance to JAK kinase inhibitors.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Meyer, Sara C SC; Levine, Ross L RL
Publication Date: 2014-04-15

Variant appearance in text: N/A
PubMed Link: 24583800
Variant Present in the following documents:
View BVdb publication page



Mechanistic insights into activation and SOCS3-mediated inhibition of myeloproliferative neoplasm-associated JAK2 mutants from biochemical and structural analyses.

The Biochemical Journal
Varghese, Leila N LN; Ungureanu, Daniela D; Liau, Nicholas P D NP; Young, Samuel N SN; Laktyushin, Artem A; Hammaren, Henrik H; Lucet, Isabelle S IS; Nicola, Nicos A NA; Silvennoinen, Olli O; Babon, Jeffrey J JJ; Murphy, James M JM
Publication Date: 2014-03-01

Variant appearance in text: JAK2: 1821G>C; K607N
PubMed Link: 24354892
Variant Present in the following documents:
  • Main text
View BVdb publication page



Predicting the functional impact of protein mutations: application to cancer genomics.

Nucleic Acids Research
Reva, Boris B; Antipin, Yevgeniy Y; Sander, Chris C
Publication Date: 2011-09-01

Variant appearance in text: JAK2: K607N
PubMed Link: 21727090
Variant Present in the following documents:
  • supp_gkr407_Supplement2_Table_SM1_COSMIC_mutations.xls, sheet 1
View BVdb publication page



A JAK2 interdomain linker relays Epo receptor engagement signals to kinase activation.

The Journal Of Biological Chemistry
Zhao, Lequn L; Dong, Hongyun H; Zhang, Cheng Cheng CC; Kinch, Lisa L; Osawa, Mitsujiro M; Iacovino, Michelina M; Grishin, Nikolai V NV; Kyba, Michael M; Huang, Lily Jun-shen LJ
Publication Date: 2009-09-25

Variant appearance in text: N/A
PubMed Link: 19638629
Variant Present in the following documents:
View BVdb publication page



Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1.

Journal Of Cellular And Molecular Medicine
Tefferi, Ayalew A
Publication Date: 2009-02

Variant appearance in text: JAK2: K607N
PubMed Link: 19175693
Variant Present in the following documents:
  • Main text
  • jcmm0013-0215.pdf
View BVdb publication page



Consistent up-regulation of Stat3 Independently of Jak2 mutations in a new murine model of essential thrombocythemia.

Cancer Research
Senyuk, Vitalyi V; Rinaldi, Ciro Roberto CR; Li, Donglan D; Cattaneo, Francesca F; Stojanovic, Aleksandra A; Pane, Fabrizio F; Du, Xiaoping X; Mahmud, Nadim N; Dickstein, Jerome J; Nucifora, Giuseppina G
Publication Date: 2009-01-01

Variant appearance in text: N/A
PubMed Link: 19118011
Variant Present in the following documents:
View BVdb publication page



Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders.

Leukemia
Walz, C C; Cross, N C P NC; Van Etten, R A RA; Reiter, A A
Publication Date: 2008-07

Variant appearance in text: N/A
PubMed Link: 18528425
Variant Present in the following documents:
View BVdb publication page



JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.

The Journal Of Molecular Diagnostics : Jmd
Steensma, David P DP
Publication Date: 2006-09

Variant appearance in text: N/A
PubMed Link: 16931578
Variant Present in the following documents:
View BVdb publication page